Quantcast
  • E-mail
  • Print
  • Comment
  • Font Size
  • Digg
  • del.icio.us
  • Discuss article

Research and Markets: Pharmaceutical's Pipeline Prospects in the Influenza Field and Potential New Treatments and Vaccines in Development

Posted on: Friday, 13 January 2006, 12:00 CST

Research and Markets (http://www.researchandmarkets.com/reports/c30824) has announced the addition of Spotlight on Influenza - Separating Fact from Fiction in the Battle Against Influenza to their offering.

Focusing on the hot topic of influenza, this report offers a topical insight into both the flu virus and the methods being employed to tackle it. From an investigative angle, the report specifically explores the pharmaceutical industry's R&D endeavours in combating the virus, affording a comprehensive insight into key players in the arena.

Main areas of focus covered by the report include:

- The virus and its history

- Key industry insight

- An analysis of the market

- Summary of influenza-related deals

In particular, the report looks at pharma's pipeline prospects in the influenza field and discusses potential new treatments and vaccines in development, while simultaneously assessing their potential marketing position and value. As well as probing the industry's ongoing investigative efforts, the report also broadly analyses and outlines the current markets, including available therapeutic products.

Looking to the future, the ramifications of the pandemic threat and its potential long-term repercussions will be reviewed from a global healthcare and commercial market perspective. The report also covers deal making and licensing opportunities, which have stemmed from the flu threat, providing an analysis of the companies and therapies involved. Background on the history of the flu, details of the different strains and viral targets for therapeutic intervention will be described in detail as a key contextualising element of this report.

This topical report provides readers with insightful competitor intelligence and extended market analysis compiled from PharmaDeals(R). You can therefore be sure that you are accessing the most up-to-date and timely information available.

Sections Covered:

Section 1: The Virus and its History

Section 2: Industry Insights

Section 3: An Eye on the Markets

Section 4: Deal Makers

For more information visit http://www.researchandmarkets.com/reports/c30824


Source: Business Wire

More News in this Category


Related Articles



Rating: 2.6 / 5 (8 votes)
Rate this article:
1/52/53/54/55/5

User Comments (0)

Comment on this article

Your Name
Text from the image
Comment
max 1200 chars
* All fields are required